StockMarketWire.com - Motif Bio, the clinical stage biopharmaceutical company specialising in developing novel antibiotics, has been selected to present at the Biotech Showcase 2016, San Francisco, on 11 January at 1400 PST; Track: D - Powell (3rd Floor).

Biotech Showcase, which runs alongside the largest healthcare investor event of the year - the JP Morgan Annual Healthcare Conference - is an investor and partnering conference dedicated to providing private and public life sciences companies an opportunity to meet with investors and pharmaceutical executives from around the world. Chief executive Graham Lumsden said: "Being selected to present at such an important event is recognition of Motif's success to date and future potential. Members of the Motif Leadership Team will be in San Francisco to meet pharma and biotech investors and partners attending the Biotech Showcase and JP Morgan conference."


At 1:52pm: [LON:MTFB] Motif Bio Plc Ord 1p share price was -1p at 52p



Story provided by StockMarketWire.com